Furthermore, small molecule inhibitors of IGF2BP1 function, including BTYNB or Cucurbitacin B, that have recently shown promising anti-tumor effects [37,127,128], should be tested for their impact on the production and infectivity of the virus species reported to benefit from IGF2BP1 expression. Here, IGF2BP1 is linked to neoplasm.